EUVIMEDEUVIMED entdecken
Validierungsstudie

External Validation of the International IgA Nephropathy Prediction Tool in a Colombian Hispanic Cohort: Insights From a Long‐Term Follow‐Up Study

Joaquín Rodelo-Ceballos iD, Ligia L Calderón-Puentes, Mauricio Restrepo-Escobar iD

Nephrology · 2026

DOI: 10.1111/nep.70174 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Nephrology, 2026. Verfasst von Joaquín Rodelo-Ceballos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Service, San Vicente Fundación Hospital, Medellín, Colombia. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To externally validate the International IgA Nephropathy Prediction Tool (IIgANN‐PT) in a Colombian Hispanic cohort with biopsy‐proven IgA nephropathy (IgAN).

Methods

We conducted a retrospective cohort study of 397 Colombian Hispanic adults with primary IgAN biopsied between 2004 and 2022 and followed through 1 April 2024. The race‐unadjusted IIgANN‐PT was applied at biopsy to predict the composite outcome of sustained 50% decline in estimated glomerular filtration rate (eGFR) or end‐stage kidney disease (ESKD). Model performance was evaluated at the pre‐specified 5‐year horizon using time‐dependent AUC and Harrell's C‐statistic for discrimination, inverse‐probability‐of‐censoring‐weighted (IPCW) Brier score for overall prediction error and calibration‐in‐the‐large (CITL) plus calibration slope (βLP) for calibration. Predicted and observed 5‐year risks were also compared across the tool's four pre‐specified linear predictor risk strata.

Results

Over a median follow‐up of 4.7 years, 132/397 (33.3%) patients reached the composite outcome. In the complete‐case analysis ( n = 234), discrimination at 5 years was excellent (AUC 0.94 [95% CI 0.89–0.97]; Harrell's C 0.88), with low overall prediction error (IPCW Brier score 0.103). Calibration was accurate on average (CITL 0.03), but the calibration slope was > 1 (βLP 1.40), indicating underprediction concentrated at the extremes; the largest underestimation occurred in the very‐high‐risk stratum (mean predicted ~67% vs. observed ~80%–85%).

Conclusion

In this Colombian Hispanic IgAN cohort, the IIgANN‐PT retained excellent 5‐year discrimination and good average calibration, but underestimated risk in the highest‐risk patients, supporting its use for risk stratification while emphasising the need for calibration assessment (and potential local recalibration) before broader implementation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, IGAAdultFemaleHumansMaleMiddle AgedColombiaDisease ProgressionFollow-Up StudiesGlomerular Filtration RateHispanic or LatinoKidney Failure, ChronicPrediction AlgorithmsPredictive Value of TestsRetrospective StudiesRisk AssessmentTime Factors

Stichwörter der Autor:innen

IgA nephropathycalibrationdiscriminationend‐stage kidney diseaseexternal validationinternational IgA nephropathy prediction toolrisk prediction

Autor:innen und Institutionen

  • Nephrology Service, San Vicente Fundación Hospital, Medellín, Colombia.
  • Department of Internal Medicine, Nephrology Section, Universidad de Antioquia, Medellín, Colombia.
  • Department of Internal Medicine, Rheumatology Section, Universidad de Antioquia, Medellín, Colombia.

ORCID-Profile: Joaquín Rodelo-Ceballos, Mauricio Restrepo-Escobar

Zitieren

APA

Rodelo-Ceballos, J., Calderón-Puentes, L. L., & Restrepo-Escobar, M. (2026). External Validation of the International IgA Nephropathy Prediction Tool in a Colombian Hispanic Cohort: Insights From a Long‐Term Follow‐Up Study. Nephrology. https://doi.org/10.1111/nep.70174

Vancouver

Rodelo-Ceballos J, Calderón-Puentes LL, Restrepo-Escobar M. External Validation of the International IgA Nephropathy Prediction Tool in a Colombian Hispanic Cohort: Insights From a Long‐Term Follow‐Up Study. Nephrology. 2026. doi:10.1111/nep.70174

BibTeX
@article{RodeloCeballos2026,
  author = {Rodelo-Ceballos, Joaquín and Calderón-Puentes, Ligia L and Restrepo-Escobar, Mauricio},
  title = {External Validation of the International IgA Nephropathy Prediction Tool in a Colombian Hispanic Cohort: Insights From a Long‐Term Follow‐Up Study},
  journal = {Nephrology},
  year = {2026},
  doi = {10.1111/nep.70174}
}
Kostenlos starten →